Vironova Biosafety
Our focus is on quality

GLP Compliance

Vironova Biosafety operates in compliance with OECD GLP guidelines and is included in the regular inspection plan of the Swedish Board for Accreditation and Conformity Assessment (SWEDAC). As stated in ICH Q5A, manufacturers of biologics are required to prove the viral removal and/or inactivation efficacy in their manufacturing process, and viral clearance studies are required to be performed in compliance with GLP principles.

Successful inspection without remarks

Swedac inspection
Arrow 33.4 Created with Sketch.

Did you know?
Vironova Biosafety was found to operate in compliance with the principles of Good Laboratory Practice (GLP) as established by the OECD and the European Community by the Swedish Board for Accreditation and Conformity Assessment (SWEDAC) when a full inspection and study audit was performed on December 20th 2017. It is specially gratifying that the GLP certificate was issued with no remarks.

Download the latest GLP certificate


Viral clearance GLP study
Viral clearance non-GLP study
Virus production or cell cultivation